Cullinan Therapeutics Files 8-K for Material Agreement

Ticker: CGEM · Form: 8-K · Filed: Jun 4, 2025 · CIK: 1789972

Cullinan Therapeutics, Inc. 8-K Filing Summary
FieldDetail
CompanyCullinan Therapeutics, Inc. (CGEM)
Form Type8-K
Filed DateJun 4, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, filing, corporate-update

TL;DR

Cullinan Therapeutics signed a big deal, filing an 8-K on June 4th.

AI Summary

Cullinan Therapeutics, Inc. filed an 8-K on June 4, 2025, reporting the entry into a material definitive agreement. The filing also includes Regulation FD disclosures and financial statements/exhibits. The company, formerly known as Cullinan Oncology, Inc., is based in Cambridge, MA.

Why It Matters

This filing indicates a significant new contract or partnership for Cullinan Therapeutics, which could impact its future operations and financial performance.

Risk Assessment

Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, but the specifics are not detailed in this initial filing.

Key Players & Entities

  • Cullinan Therapeutics, Inc. (company) — Registrant
  • Cullinan Oncology, Inc. (company) — Former company name
  • June 04, 2025 (date) — Date of earliest event reported
  • Cambridge, Massachusetts (location) — Company address

FAQ

What is the nature of the material definitive agreement entered into by Cullinan Therapeutics?

The filing states that Cullinan Therapeutics, Inc. entered into a material definitive agreement, but the specific details of this agreement are not provided in the summary information.

When was this 8-K filing submitted?

The 8-K filing was submitted on June 4, 2025.

What were Cullinan Therapeutics' former company names?

Cullinan Therapeutics, Inc. was formerly known as Cullinan Oncology, Inc., Cullinan Management, Inc., and Cullinan Oncology, LLC.

Where is Cullinan Therapeutics, Inc. located?

Cullinan Therapeutics, Inc. is located at One Main Street, Suite 1350, Cambridge, Massachusetts, 02142.

What is the SIC code for Cullinan Therapeutics, Inc.?

The Standard Industrial Classification (SIC) code for Cullinan Therapeutics, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 4, 2025 regarding Cullinan Therapeutics, Inc. (CGEM).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.